Empirical treatment of neonatal sepsis: Are the current guidelines adequate?

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 1, 2011, Pages

  Muller Pebody, B ^a   Johnson, A P ^a   Heath, P T ^b   Gilbert, R E ^c   Henderson, K L ^a   Sharland, M ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; FLUCLOXACILLIN; GENTAMICIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMBINATION CHEMOTHERAPY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE;

AGE OF ONSET; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; ENGLAND; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; WALES;

EID: 78650806101     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2009.178483     Document Type: Article

References (31)

1. Modi N, Doré CJ, Saraswatula A, et al. A case definition for national and international neonatal bloodstream infection surveillance. Arch Dis Child Fetal Neonatal Ed 2009;94:F8-12.
2. McDuffie RS Jr, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol 1993;82:487-9.
3. Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005;24:635-9.
4. Nambiar S, Singh N. Change in epidemiology of health care-associated infections in a neonatal intensive care unit. Pediatr Infect Dis J 2002;21:839-42.
5. Gilbert R. Prenatal screening for group B streptococcal infection: gaps in the evidence. Int J Epidemiol 2004;33:2-8. (Pubitemid 38500144)
6. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292-4.
7. Musoke RN, Revathi G. Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications. J Trop Pediatr 2000;46:86-91. (Pubitemid 30232543)
8. Nambiar S, Herwaldt LA, Singh N. Outbreak of invasive disease caused by methicillin-resistant Staphylococcus aureus in neonates and prevalence in the neonatal intensive care unit. Pediatr Crit Care Med 2003;4:220-6.
9. Sherer CR, Sprague BM, Campos JM, et al. Characterizing vancomycin-resistant enterococci in neonatal intensive care. Emerging Infect Dis 2005;11:1470-2.
10. Toltzis P. Antibiotic-resistant gram-negative bacteria in hospitalized children. Clin Lab Med 2004;24:363-80. (Pubitemid 38737257)
11. Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005;49:760-6.
12. The Paediatric Formulary Committee. BNF for children. British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatrics and Child Health, Neonatal and Paediatric Pharmacists Group, 2008.
13. Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother 2008;61:743-5.
14. Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-16.
15. Berger A, Salzer HR, Weninger M, et al. Septicaemia in an Austrian neonatal intensive care unit: a 7-year analysis. Acta Paediatr 1998;87:1066-9.
16. Hyde TB, Hilger TM, Reingold A, et al. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002;110:690-5.
17. McGuire W, Clerihew L, Fowlie PW. Infection in the preterm infant. BMJ 2004;329:1277-80.
18. Sharland M. The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup. J Antimicrob Chemother 2007;60(Suppl 1):i15-26.
19. CDC. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC. MMWR Morb Mortal Wkly Rep 2002;51:1-22.
20. Colbourn TE, Asseburg C, Bojke L, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ 2007;335:655.
21. RCOG Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease - guideline no. 36. Guidelines and Audit Committee of the RCOG. 1 November 2003, London.
22. Lautenbach E, Polk RE. Resistant gram-negative bacilli: a neglected healthcare crisis? Am J Health Syst Pharm 2007;64:S3-21; quiz S22-4.
23. Orsi GB, d'Ettorre G, Panero A, et al. Hospital-acquired infection surveillance in a neonatal intensive care unit. Am J Infect Control 2009;37:201-3.
24. Huang SY, Tang RB, Chen SJ, et al. Coagulase-negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Microbiol Immunol Infect 2003;36:51-5.
25. Isaacs D. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed 2003;88:F89-93.
26. Gilbert DN, Moellering RC, Eliopoulos GM, et al. Comparison of antimicrobial spectra. In: The Sanford guide to antimicrobial therapy 2008. Sperryville, Virginia, USA: Antimicrobial Therapy, 2008:65-70.
27. Bryan CS, John JF Jr, Pai MS, et al. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child 1985;139:1086-9.
28. de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000;355:973-8.
29. Modi N, Damjanovic V, Cooke RW. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child 1987;62:148-51. (Pubitemid 17004195)
30. Le J, Nguyen T, Okamoto M, et al. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. Pediatr Infect Dis J 2008;27:314-18. (Pubitemid 351483065)
31. Hope R, Livermore DM, Brick G, et al. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008;62(Suppl 2):ii65-74.